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PREFACE 
In the early morning of August 6, 1945, the American 
B-29 bomber "Enola Gay" lifted off the runway in the Marianas and 
motored westward over the Pacific, toward the archipelago of Japan. 
Its destination was the city of Hiroshima, situated in western Honshu. 
At 8:15 am a 12.5 kiloton atomic bcmb was let dcwn by parachute 
and detonated, 576 meters above the city. Below, it left a circular 
wasteland of life and form. An area 13.2 km was leveled. Loss 
of civilian life was numbered at 78,150. More than half that number 
were either injured or missing. The casualties sustained by the 
military personnel have never been reported. Within three days 
the city of Nagasaki, nestled at the edge of the southern island 
of Kyushu, became the second and hopefully last city in the world 
to fall witness to the cataclysmic capacity of nuclear warfare. 
On August 9th,a 22 Kiloton plutonium bomb was exploded 507 meters 
above the harbor city, taking the lives of 23,753 people. Another 
23,345 were left injured with 1,924 missing in the rubble. 
And so the war ended, the Occupation forces arrived and 
Japan miraculously pulled itself back up from the dust; but Hiroshima 
and Nagasaki continued to limp - crippled by radiation effects. 
Most of these effects were biological realities. Sane were unsubstan¬ 
tiated fears fostered by the imagination of anxious survivors. Rad¬ 
iation injury was a disease fashioned by man, but poorly understood by 
him. The entire world was watching Hiroshima and Nagasaki and in the 
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ensuing thirty years we learned same grim lessons through the study 
of radiation biology in these two cities. 
This thesis was written in Hiroshima daring the early 
part of 1976. The majority of data was gleaned in a rather 
dispassionate manner from magnetic tape files and coverslip slides. 
Please remember that these lifeless numbers came frcm living people- 
the many survivors of Hiroshima and Nagasaki who count themselves 
among the millions of innocent people victimized by wars they barely 
understood. It would be a sacrilege to launch into a dissertation 
on radiation effects without first giving praise to the people 
of both these cities who have so willingly and graciously cooperated 
in their followup care. 
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THE RADIATION EFFECTS RESEARCH FOUNDATION 
The work for this thesis was carried out at the Radiation 
Effects Research Foundation (RERF) in Hiroshima, Japan. RERF was formerly 
known as the Atonic Bcmb Casulaty Cormission (ABCC) , a research organ¬ 
ization established in 1947 by a directive of the President of the 
United States. It emerged under the guidance of the National Academy 
of Sciences-National Research Council - its extended mission was to 
monitor the health of the survivors of the atomic borbs.. It was 
hoped that, through the study of this population, we might document 
and perhaps cone to understand and control the damaging effects of 
radiation. This knowledge would be essential as the world began 
to realize the peaceful potential of atomic energy. 
Initially, ABCC was funded by the Atomic Energy Commission 
with additional monies in later years coming frcm the U.S. Public 
Health Service, the National Cancer Institute, and the National 
Institute of Heart and Lung Diseases. In 1948 the Japanese 
became co-participants in the studies through the cooperation of 
the Japanese National Institute of Health. 
In April, 1975, after twenty-eight years of operation, 
ABCC was superseded by the Radiation Effects Research Foundation 
which is organized as a private Japanese foundation, sponsored 
by the Japan Ministry of Health and Welfare and the foreign Ministry. 
It is funded equally by the governments of Japan and the United 
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States. American support is provided through the National Academy 
of Sciences under contracts with the Energy Research and Development 
Administration (ERDA), the National Cancer Institute and the National 
Institute of Heart and Lung Diseases. In the fashion established 
by ABCC, RERF has laboratory and examination facilities in both 
Hiroshima and Nagasaki. There is an ongoing research effort in 
both cities with concerted study of radiation effects at many 
different levels, frcm systematic biennial clinical evaluations of 
an adult population to meticulous biochemical genetic studies on 
the fi generation -of survivors. An excellent review of the major 
findings of the Atonic Bomb Casualty Carrmission has been recently 
published (1). 
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INTRODUCTION 
The acute, chronic, and latent effects of exposure to 
ionizing radiation are protean. They have been extensively 
researched and recorded in both human and animal models. At the 
Atonic Bonb Casualty Ccmmission, over thirty years of research was 
completed and a large library of technical reports has been compiled. 
Most of these reports have subsequently appeared in the medical 
literature throughout the world. Aside frcm the acute effects of 
exposure to radiation there are many persistent effects, most of 
which have been elucidated frcm a systematic evaluation of the large 
population of survivors in both Hiroshima and Nagasaki. Statistical 
studies have documented, an increased incidence of leukemia (2-4) and 
thyroid carcinoma (5) as well as a probable increase in the occurrence 
of other solid tumors (6) in the more heavily irradiated survivors 
(in particular lung and breast carcinoma (7-11)). Radiation ''markers" 
isolated at ABCC include chrcmoscmal aberrations in circulating 
leukocytes (12-13), radiation cataracts (posterior lenticular opacities) 
(14) /microcephaly, and mental retardation amongst those exposed in- 
utero (15) as well as a slight dimunition in growth and development 
among children exposed at a very young age. Che of the most sign¬ 
ificant and encouraging findings to date involves the evaluation of 
over 70,000 f]_ children which failed to demonstrate any clinical 
evidence of a radiation effect (16). 
This thesis was not conceived as a treatise on radiation 
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biology nor as an enccmpassing review of "radiation effects". It 
was begun with the idea that by evaluating the extent of radiation 
damage in a selected organ system one might be able to approximate 
the dose of ionizing radiation that that particular organ system 
had received, i.e. to use the magnitude of specific organ damage 
as a biologic dosimeter. The majority of persons exposed during 
the atomic bombings have had so called T65D doses calculated for 
then. (A discussion of T65D doses can be found in the 2nd section 
of parti). There remains, however, a substantial population of 
survivors of whom T65D could not be calculated. This group of 
survivors is usually included in the "unknown" dose group in any 
major population study at RERF and the uncertainty of their extent 
of exposure has hampered many studies. This has been particularly 
true when investigating the incidence of low frequency diseases (such 
as breast cancer) where the absolute number of cases is small and 
the presence of several "unknown" patients has a marked effect on 
the statistical significance of the results. If by evaluating a 
potential radiation marker (biologic dosimeter) one might give a 
rough dose estimate to a subject with previously unknown dose, these 
"unknown" dose individuals might then be included in the numerous 
statistical studies that are being conducted at RERF. It should 
be emphasized that the potential for biologic dosimeters extends 
beyond the facilitation of statistical analysis in Hiroshima and 
Nagasaki. In the event of any nuclear accident or catastrophe, the 
evaluation of biological aberrations would have both diagnostic 
and prognostic importance. 
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THESIS: 
This thesis will describe an evaluation of gradients 
between dose, and the frequency of abnormalities, in two potential 
"late" radiation markers- bone marrow cytology and absolute lymphocyte 
counts. Both investigations were carried out on selected patients 
with established exposure doses. The two systems- bone marrow 
cytology and absolute lymphocyte counts were analyzed in an attempt 
to establish biologic dosimeters which would, in turn, facilitate 
the estimation of.exposure doses-for unknown survivors. 
The thesis is divided into two independent sections. 
I. BONE MARROW OTOLOGY - 1950 - Five years post-exposure 
to whole body irradiation. Hiroshima, Japan. 
II. THE EFFECTS OF RADIATION ON ABSOLUTE LYMPHOCYTE 
COUNTS IN THE ADULT HEALTH STUDY SAMPLE 
HIROSHIMA-NAGASAKI, JAPAN. 
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PART I. BOSE MARROW CYTOLOGY - 1950 - Five years post exposure 
to whole-body irradiation. Hiroshima/ Japan. 
Section 1. Introduction 
A study was undertaken to evaluate the "late" (five year) effects 
of mixed gamma-neutron irradiation on the bone marrcw cytology of a 
group of survivors of the atomic bomb in Hiroshima. 
The acute effects of radiation on hematopoietic tissue 
have been well documented. Investigations in Hiroshima and Nagasaki 
in addition to experiences with accidental fallout (7) nuclear 
reactor and accelerator accidents (18-19) therapeutic and diagnostic 
radiology (20) as Well as experimental animal studies (21) have pro¬ 
vided a vast amount of data on the early perturbations of hematologic 
parameters immediately following whole body irradiation. 
Blaisdell has reviewed the ABCC hematologic studies • 
that were carried out in Hiroshima and Nagasaki during the years 
1947-59 (22). The earliest hematologic findings from these two cities 
were reported by Le Roy in 1950(23-24). The data in his report 
includes both the evaluations by the Joint Commission for the 
Investigation of the Atcmic Bomb (which functioned from the 26th 
September - 16th December/ 1945) as well as the initial studies of 
Japanese physicians and field workers who performed blood exam¬ 
inations prior to the formation of the Joint Ccsnmission. These 
early reports were recorded under cartpromised conditions. A 
systematic/ well controlled examination could not have been per¬ 
formed at that time. 
Little is known about the acute changes in the bone 
8 

marrow of Hiroshima survivors as few aspirates were obtained in 
the first days following the atonic blast. Many examinations 
were performed later, at four to six weeks, and revealed hypoplastic 
marrows with a return to what was considered a normal pattern 
of myelopoiesis and megakaryopoiesis at approximately seven to 
eight weeks- post irradiation. Erythropoiesis was found to lag, 
returning to normal around the tenth to twelfth week. By the 
sixteenth week, bone marrow samples from the survivors were 
described as oonpletely normal (22). 
Many "late" (non acute) bone marrow examinations were 
performed at ABGC in the years following its inception in 1947. A 
statistical evaluation of this data has unequivocally documented a 
dramatic increase in the incidence of leukemia (all series except 
chronic lymphocytic) amongst the survivors of Hiroshima and Nagasaki 
during the early years following the blast. More recently, the 
incidence of hematologic malignancies still remains moderately 
elevated (2,7,25). Thousands of bone marrow aspirates were obtained 
at ABCC as part of the clinical investigation of suspected leukemic 
or pre-leukemic states, as well as refractory anemias and throm¬ 
bocytopenias. There is no record of "late" bone marrow samples from 
non-leukemic survivors having been studied for persistent cytologic 
abnormalities. 
THESIS: 
To review a set of bone marrow aspirates obtained from 
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Hiroshima survivors in 1950/ five years after exposure, in an attempt 
to isolate and describe cytologic abnormalities. In addition, to 
analyze the frequency of abnormalities as a function of exposure 
dosage looking for a possible gradient. 
Section 2 
MATERIALS: 
Slides were recently recovered frcm fifty-four bone marrow 
aspirations performed on a group of heavily exposed Hiroshima 
survivors who were part of a radiation cataract study. These aspirates 
were obtained in 1950, five years following exposure to mixed gamma- 
neutron radiation frcm the Uranium^5 atonic bomb explosion in 
Hiroshima. These marrow aspirates were part of an extensive clinical 
and laboratory investigation that was carried out on seventy-eight 
survivors with documented radiation cataracts (posterior lenticular 
opacities). The purpose of the study was to determine if other 
late manifestations of radiation injury existed in this population 
with known radiation induced ophthalmological disease. The initial 
findings frcm this study were reported by Fillmore (26) . No other 
disease attributable to the atcmic bomb was detected. Fillmore's 
only reference to the bone marrow samples obtained was that.. "none 
% 
gave evidence of serious disease. " No other review of this set of 
bone marrows was subsequently undertaken. 
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Of the 54 patients for wham bone marrow slides were 
available, T65D doses* were calculated for 45. The distribution 
of subjects with different doses is seen in Table below. 
TABLE I 
Number of subjects T65D doses (rad) 
3 - greater than 1000 r 
4 - 751-1000 r 
10 ----- 501-750 r 
9  401-500 
9 ---- 301-400 
8  201-300 
1 -- 101-200 
1  less than 100 r 
9  not calculated 
The distribution included 30 males and 24 females with ages between 
12 - 69 years. Control specimens were not drawn at the time of 
*T65D doses: In the late 60's and early 70*s T65D dose became 
available for the majority of survivors in Hiroshima and Nagasaki. 
T65D refers to a particular dosimetry system which was first 
proposed in 1965 by collaborators at Oak Ridge National Laboratory 
and the Japanese National Institute of Radiological Sciences. 
Eadh dose estimate is calculated frcm data derived frcm detailed 
histories which extracted information regarding location and 
shielding at the time of the blast. The dose estimate can be 
separated into neutron and ganma contributions and is believed 
to be accurate to within approximately 30% for individual survivors 
(27-28). It was not possible to calculate T65D doses in same 
cases. These included people whose shielding configuration at 
the time of the blast was too complex for dose estimation 
(e.g. exposure in a crowded street-car). There was also a 
sizable number of people, including small children, who were 
unable to remember the details of their location at the time of" 
the blast. (Continued on next page) 
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the ophthalmology study in 1950. A search of the REEF bone marrcw 
files was made in an attempt to locate suitable controls. Only 
five samples were felt to be adequate. None of the controls were in 
the city at the time of the blast. See table II. 
TABLE II. Controls: 
AGE SEX 
48 F 
2 M 
62 M 
62 F 
75 M 
Section 3 
METHODS: 
YEAR DIAGNOSIS 
1963 menorrhagia 
1952 hepatomegaly 
1958 Laennec's cirrhosis 
1969 hemosiderosis 
1957 pernicious anemia in 
remission 
Specimens without T65D dose assignment were deleted frcm 
the study. Also deleted were nine marrows which were felt to be 
of too poor quality to be adequately reviewed. The five controls 
were added to the regaining thirty-five marrows from the ophthalmology 
study, and each marrow was then reviewed blindly without knowledge 
of exposure dosage. When possible, 4000 erythroblasts (including 
proerythroblasts, early and late basophilic normoblasts, poly- 
chrcmatophilie and oxyphilic normoblasts) were counted for each 
T65D is not a whole body dose but represents the first collision 
absorbed dose to a small mass of tissue in the radiation field, 
where the survivor was located at the time of exposure. The total 
dose is computed fresn the sum of gamna and first collision neutron 
doses in rad. (1 rad = 100 ergs/g=10“2j/kg). In the near future 
dosimetry calculations will permit specific tissue dose estimates 
e.g. bone marrow doses. 
12 

patient* In the course of counting 4000 erythroblasts, cytologic 
abnormalities, as they occured, were recorded. Particular attention 
was paid to abnormalities which have been associated with radiation 
injury in previously reported studies (29). These included bi- and 
trinucleated cells, chromosomal bridging in ana- and telephase, 
nuclear fragments (karyoreres), abnormal mitoses, hypersegmentaticn 
and giant nuclei. Myeloid precursors were not enumerated, though 
aberrations in this cell line were noted in relation to the 4000 
erythroblasts counted. Histologic evaluation of a selection of 
bone marrow smears was performed without knowledge of radiation dose 
by an additional experienced hematologist* for purpose of verification. 
The clinical charts for the exposed individuals were 
available for review. Pertinent information obtained from the charts 
included the following clinical data; recorded at the time of marrow 
aspiration in 1950. 
a. Hematologic parameters (PBC, HGB, HCT, indices, reticu¬ 
locyte count, WBC and differential count) 
b. Clinical state 
c. Parasitology (stool) 
d. Mycology (sputum for AFB) 
e. Serology 
% 
The .subsequent clinical course over the following years was also 
noted. 
* Dr. Stuart C. Finch, Chief of Research at REEF 
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Section 4 
RESULTS: 
A surrmary of findings for each bone marrow aspirate 
reviewed can be found in Table III. The most frequent abnormality 
noted was binucleation of cells in the erythrocytic series. 
Binucleated erythroblasts were divided into "early" and "late" 
according to the maturation characteristics of their nuclei and 
cytoplasm* Figures 1-4 and 5-6 give examples of both. "Early" 
erythroblasts included pronormoblasts and basophilic normoblasts. 
The transition between basophilic normoblast and polychromatophilic 
normoblasts provided a vague dividing line between "early" and 
"late" erythroblasts. Any cell that was clearly identified as a 
polychrcmatophilie normoblast or orthochromatic normoblast was included 
in the "late" binucleated series. 
Scans uncertainty arose when attempting to differentiate 
a true binucleated cell from a mitotic cell, late in anaphase, 
prior to initiation of cytokinesis. In this study, a cell 
was considered to be a "late" mitotic cell if the cytoplasm was 
overtly elliptoid with extreme eccentricity of the nuclei. Figures 
7-8 j or if the nuclear chromatin was not uniformly condensed. 
Figures 9-10. 
In carparing the frequency of binucleated cells (either 
"early" or "late" erythroblasts) per 1000 erythroblasts, no stat¬ 
istically significant difference between different dose groups and 
the controls was demonstrated (Table IV). Late mitoses, as defined 
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above, were also enumerated. Statistical analysis failed to reveal 
a gradient with dose. 
The frequency of karyaneres (Table V ) was found to 
be independent of dose although the 600+ rad group had a striking 
incidence of 8 per 1000 erythroblasts. Examples of Karyaneres can 
be seen in figures 10-14. 
Mitotic bridging ("bridging" of chromosomal material 
between segregating fragments (figures 15-19) was noted only in the 
exposed samples though a gradient with dose was not demonstrated 
(Table V). Because the number of controls is small, the absence of 
bridging within this group is not statistically significant. 
Intemuclear bridges between interphase erythroid cells, 
(figures 20 - 25); were noted in seven marrows. All 
but one (#52- dose 140 r) had and exposure of greater that 300 rad. 
Strict criteria were used for identifying intemuclear bridges. Many 
examples of intercytoplasmic bridging were noted but 
only those cells which were clearly linked frcm nucleus to nucleus 
with a fine strand of chromatin like material were counted. Though 
internuclear bridging was not observed in controls, their paucity 
% 
precluded establishment of any statistical significance. 
Mitotic figures were enumerated in the course of counting 
4000 erythroblasts. When possible, they were differentiated as 
myelocytic or erythrocytic. Most were undetermined. A very 
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rough mitotic index (total number of mitoses, erythroid, myeloid, 
and undetermined combined, per 1000 erythroblasts) is reported in 
Table VI. There does appear to be a gradient with dose. This 
finding is suggestive but not significant (.05<p<.10). 
Other rare findings in selected marrcws included tri and 
quadranucleated erythroid and myeloid cells (figures 26-29) as well 
as binucleated plasma cells (figures 30-31), hypersegmentation, 
(figure 32) (only one case), and several instances of apparent 
multipolar mitoses. (figures 33-36). Though none of these abnor¬ 
malities were noted.in the controls, statistical significance cannot 
be attached. 
There was excellent verification of the described bone 
marrow findings by the other hematologist, who examined selected 
marrow smears. There also was essential agreement between the 
examiners regarding the interpretation of several hundred photo¬ 
micrographs of various cytologic aberrations which were observed 
by the primary examiner. 
Medical records for thirty-two of the thirty-six exposed 
patients were available for review. Analysis of hematologic 
parameters at the time of bone marrow aspiration did not reveal 
anemia (all hemoglobin values greater than ten grams percent) or 
reticulocytosis (all reticulocyte counts less than 1.3 percent) 
in any of the cases. There were 17 cases of intestinal parasitism 
which were demonstrated in stool specimens obtained at the initial 
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clinic examination in 1950. This parasitism was emphasized by 
the absolute eosinophilia noted at the same time. Cfcmmon 
parasites included Ascaris lumbricodese, hookworm, and T. trichiurus. 
It should be enphasized that despite the frequency of parasitism, 
anemia was not present in any of these cases. The remaining 
examination in 1950 included a complete physical exam, serology, 
urinalysis, and chest roentgenograms. No active disease process 
other that posterior lenticular degeneration was detected, excepting 
two cases of pulmonary tuberculosis 
The clinical course subsequent to 1950 could be followed 
for a majority of the exposed individuals. Of eleven deaths noted 
in the ABCC files, the average age at death was 75. One subject 
(#40) died in 1962 at the age of 40 of gastric carcinoma. There were 
two other deaths secondary to gastric carcinoma (#2, #42). The 
remaining causes of death had no apparent relation to previous 
radiation exposure.* 
*An increased incidence of gastric carcinoma has not been linked 
to radiation exposure. These three cases of gastric carcinoma were 
isolated from the other eight deaths since they are cancers, and 
radiation is known to be carcinogenic. 
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TABLE III 
CYTOLOGY OF INDIVIDUAL BONE MARROWS 
SPECIAL BONE MARROW DIFFERENTIAL STUDIES, FIVE YEARS FOLLOWING EXPOSURE, HIROSHIMA 
Case 
No. 
M .F. 
No. 
D
os
e 
in
 
R
ad
 
E
ry
th
ro
b
la
st
s 
C
ou
nt
ed
 
Binucleated Cells 
Late 
Mitosis 
Tri/Quad 
Nucleated 
Karyomeres 
In
te
rn
u
c
le
a
r 
B
ri
d
g
e 
M
it
o
ti
c
 
B
ri
d
g
e 
Mitosis 
E
ar
ly
 
E
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th
ro
cy
te
s 
_
_
 
L
at
e 
E
ry
th
ro
cy
te
s 
M
y
el
o
cy
te
s 
E
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th
ro
cy
te
s 
M
y
el
o
cy
te
s 
E
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th
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c
y
te
s 
M
y
el
o
cy
te
s 
E
ry
th
ro
cy
te
s 
M
y
el
o
cy
te
s 
U
n
de
te
rm
in
ed
 
T
o
ta
l 
1 216 373 440 4000 9 13 2 14 1 myelo 3 4 4 7 8 19 34 
2 241 305 212 650 
- 
2 1 3 2 5 
5 257 711 755 4000 1 5 1 4 1 7 8 34 49 
6 400 428 443 4000 2 12 2 14 3 2 4 2 3 45 50 
7 238 499 707 4000 5 11 3 14 4 1 2 2 14 42 58 
8 242 288 348 4000 10 14 1 10 2 1 tri lquac 1 8 46 
9 277 937 313 4000 4 4 2 20 19 2 5 3 2 2 21 25 
10 234 111 540 4000 3 4 10 2 2 1 1 35 37 
14 236 627 567 3000 
- 3 1 1 3 2 1 3 4 8 
15 320 482 380 4000 4 13 1 7 2 3 3 4 9 37 
16 215 018 997 4000 2 5 1 1 2 3 13 7 32 52 
17 301 208 432 3000 1 15 1 3 2 1 1 2 2 24 28 
19 256 830 1041 4000 2 3 5 2 1 27 
20 299 397 269 4000 
- 6 1 6 3 1 1 23 21 
22 298 391 511 4000 1 7 
- 
7 3 2 4 4 18 26 
23 242 305 382 1750 1 6 3 3 3 1 0 2 14 16 
25 242 574 NIC 4000 2 10 1 5 3 1 1 4 39 44 
26 299 .233 228 4000 4 14 2 2 1 quad 8 2 4 1 5 49 55 
27 241 276 322 4000 2 7 1 3 2 1 1 5 19 21 
28 259 746 382 4000 2 13 1 3 7 2 1 1 39 
Bone marrows not looked at: 3, 4, 12, 13, 18, 24, 29, 35, 51 

TABLE III continued 
30 240 781 NIC 3000 2 4 9 1 
31 400 896 711 4000 1 13 1 10 
32 252 508 478 4000 2 10 
- 
1 
33 268 304 293 4000 
- 5 - 4 
36 306 758 96 4000 2 15 1 3 
37 244 911 552 4000 
- 
7 2 5 
40 282 568 652 4000 2 11 
- 4 
42 244 512 206 2000 
- 
5 1 4 
45 323 591 280 3500 
- 
15 3 1 
46 269 530 401 4000 
- 10 2 8 
47 314 612 NIC 4000 - 10 - 7 
48 400 939 1568 3000 
- 10 1 - 
49 294 619 625 1000 1 4 - 5 
50 400 932 434 4000 - 2 3 1 
52 242 896 140 4000 4 13 - 2 
53 474 938 NIC 1700 1 2 - 4 
54 255 088 336 4000 1 10 3 3 
55 478 435 NIC 4000 - 4 - 9 
56 282 584 474 4000 2 6 - 3 
57 300 792 317 4000 2 10 2 6 
59 256 178 203 4000 - 11 2 5 
Tri/Quad 
Nucleated 
Karyomeres Mitosis 
1 quad 1 tri 3 
1 
1 tri 
4 
1 
1 tri myelo 
13 
2 
10 
1 quad (?) 
2 1 
11 
12 16 
35 44 
29 37 
20 
14 23 
17 21 
16 23 
17 
28 30 
6 18 
18 
18 
11 13 
15 
37 41 
13 
20 38 
8 
34 
31 
18 7 

TABLE IV 
MITOTICALLY CONNECTED ABNORMALITIES 
A.Binucleated and "late" mitotic cells 
BINUCLEATED LATE 
CELLS TOTAL MITOTIC 
n "EARLY" "LATE" BINUCLEATED CELLS 
TOTAL 
BINUCLEATED + 
LATE MITOTIC 
p/NIC 5 0.35 
(0.15) 
1.70 
(0.33) 
2,05 
(0.34) 
U52 
(0.37) O 
b
l 
OO
 
p
. 
1-199 
DOSE 
GROUP 
2 1L.Z5 
(0.13) 
3.50 
(0.25) ( - ) 
0.62 
(0.13) 
4*22 
(0.13) 
frad-) 200-399 15 0.53 
(0.18) 
2.62 
(0.24) 
3.16 
(0.31) 
1,46 
(0.32) 
4,61 
(0.43) 
.400-599 11 0.44 
(0.17) 
2,10 
(0.37) 
2.54 
(0.44) 
JL54 
(0.36) 
4,08 
(0.6S) 
600+ S 0.49 2.42 2.90 1.61 4.51 
(0.12) (0.42) (0.46) (0.56) (0.94) 
DIFFERENCE 
IN MEANS 
NS NS NS NS NS 
«n: number of marrows;NS:not significant p .05) 
Standard error in parenthesis. 
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TABLE V 
MITOTICALLY CONNECTED ABNORMALITIES 
B. Karyomeres, Mitotic Bridges 
n 
KARYOMERES 
MITOTIC BRIDGES 
DOSE GROUP (rad) 
DIFFERENCE 
0/NIC 1-199 200-399 400-599 600+ IN MEANS 
5 2 15 11 8 
JL.Q5 
(0.55) (0.15) 
un (0.32) 0.4b (0.10) 8.00* (1.20) 
NS 
.1 -Q..-25. 0.38 TSTTl) .0^3 (0.1T) 0.36 (TCT5) NS 
*One case had 10 karyomeres; std.error in parentheses 
TABLE VI 
ROUGH MITOTIC INDEX 
DIFFERENCE 
0/NIC 1-199 200-399 400-599 600+ IN MEANS 
n 5 2 15 11 8 
TOTAL MITOSES 
per 1000 
erythroblasts 
6.10 
(1.52) 
8.00 
(2.25) 
7.92 
(0.62) 
7.38 
(0.92) 
10.00 suggestive 
(1.15)(.05 p .10) 
Includes mitoses in both erythroid and myeloid lines. 
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Figure 1. "Early" binucleated ervthroblast 
Figure 2. "Early" binucleated erythroblast 
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Figure 3. "Early" binucleated erythroblast 
Figure 4. "Early" binucleated erythroblast 
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Figure 5. "Late" binucleated erythroblast 
Figure 6. "Late" binucleated erythroblast 
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Figure 7. Late mitosis (erythroblast). 
Note elliptoid cytoplasm with eccentricity 
of the nuclei. 
Figure 8. Late mitosis (erythroblast) 
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: 
Figure 9. Late mitosis (erythroblast) 
Nuclear chromatin not uniformly condensed. 
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Figure 11. Karyaneres in an erythroblast 
Figure 12. Karyanere 
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Figure 13. Karyanere 
Figure 14. Karyanere 
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Figure 15. Mitotic "bridging" 
30 
. 
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Figure 19. Bizarre mitotic "bridging" 
Figure 20. Intemuclear Bridge. 
Two erythroblasts with a bridge of chrcmatin. 
sheathed in cytoplasm. 
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Figure 21. Intemuclear bridge 
Figure 22. '.Intemuclear bridge 
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Figure 23. Internuclear bridge 
Figure 24. Internuclear bridge 
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Figure 25. Intemuclear bridge 
Figure 26. Multinucleated erythroblast 
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Figure 27. Multinucleated precursor 
(probably eryt±iroid] 
Figure 28. Trinucleated erythroblast 
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Figure 29. Trinucleated rryelocyte 
Figure 30. Binucleated plasma cell 
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Figure 31. Binucleated plasma cell 
Figure 32. Hypersegmented neutrophil 
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Figure 33. Multipolar mitosis 
Figure 34. Multipolar mitosis 
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Figure 35. Multipolar mitosis 
Figure 36. Multipolar mitosis 

Section 5 
DISCUSSION; 
In evaluating the occurence of cytologic abnormalities 
in a bone marrow specimen prepared by ordinary coverslip technique, 
one should be aware of the variation in cellularity, structure, and 
staining properties frcm field to field within the same slide. 
In this study the majority of abnormalities were noted to be within 
the erythroblast series and were reported as a relative number, i.e. 
abnormal cells per 1000 erythroblasts. Thus variation in cellularity 
probably was not an important factor. The specific abnormalities 
most frequently noted were for the most part, independent of any 
staining properties and thus the present data is believed to be 
reliable. 
The examination of bone marrow sections would have been 
most desirable and it would have been helpful if more "low dose" 
and control marrow smears had been available for study. Nonetheless, 
the availability of some controls of bone marrow smears frcm 
individuals exposed to a wide range of relatively high doses has made 
it possible to look for dose related effects. Observer bias was 
not a factor since all cytologic studies were done without knowledge 
of exposure. 
Although cytologic abnormalities were abundant in the 
"late" bone marrows, no clear gradient with dose was established nor 
was there a statistical difference from controls. 
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The only convincing demonstration of the "late" effects 
of ionizing radiation, vis-a-vis abnormal bone marrow cytology, 
stems from a nuclear reactor accident at Oak Ridge in 1958 (18). 
Eight men were exposed to mixed gamma-neutron irradiation as 
the result of a critical excursion during the processing of 
waste Uranium235# Five of the men received "high" dose exposure 
with estimated whole body irradiation between 236-365 rad. 
Three in the "low" dose group had estimated exposures of 68.5, 68.5, 
and 22.5 rad, respectively. Serial bone marrow aspirations were 
performed on this group during the immediate post-exposure period 
and were reported by Fliedner et al (30) • Two types of cytologic 
abnormalities were described in these early marrows: (1) Ceils 
injured directly and (2) "mitotically connected abnormalities" 
(noted in both mitotically active cells and interphase cells). 
For mitotic cells in ana- or teleophase, Fliedner described 
"bridges" of chromosomal material between separating fragments. 
He also described cells late in anaphase in which a chromosome 
or chromosomal fragment had strayed from the mitotic spindle, thus 
removed from further karyokinesis. Mitotically connected abnormalities 
in interphase cells included nuclear fragments (karycmeres), bi- 
nucleated cells and "giant" cells of the myelocytic series. 
Three and one half years following the accident at 
Oak Ridge, followup bone marrow aspirations on these same individuals 
ware obtained. Control specimens from four healthy men of comparable 
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age were also drawn. The results were reported in a second paper 
by Fliedner et al (29) . The most significant finding in these 
"late" marrows was an increased number of binucleated and, occasionally, 
trinucleated erythroblasts. An increased number of erythroblasts 
with karyaneres was also reported though its significance was 
not established. Amongst cells in mitosis they reported the frequent 
occurence of chromosomes or chromosomal fragments discarded from 
karyokinesis. Two examples of tripolar mitoses were noted in the 
course of counting 15,000 erythroblasts frcm the high dose group. 
Fliedner et al. focused on the occurence of binucleated 
erythroblasts. They determined the frequency of binucleated 
red cell precursors per 1000 erythroblasts and reported a mean 
of 5.8 for the 5 men in the high dose group and 2.25 for the 2 
men in the low dose group and 1.2 for the control cohort. While 
the difference between the high dose group and the control was 
statistically significant, that between the lew dose and control 
was not. Our study did not demonstrate a statistical difference 
between exposed and controls. For our exposed group, the mean 
values for the frequency of binucleated erythroblasts per 1000 
erythroblasts was considerably lower than the mean value for 
Fliedner's high dose group. It was thought that the difference 
between these data and Fliedner's might be due to different 
criteria for distinguishing late mitoses frcm binucleated cells. 
When reviewing these marrows, Cronkite (31) states that he considered 
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a cell to be binucleated and not in mitosis if he saw nothing 
connecting the two nuclei and if there was no significant 
constriction of the cytoplasm. Fliedner (32) relied on the 
nuclear chromatin structure, stating that a cell late in anaphase 
has not completed its nuclear membrane and the chromatin pattern 
is not yet distinct. Feeling that we had perhaps been too strict 
in our criteria for distinguishing binucleated cells, a statistical 
analysis was performed using the sum of total binucleated cells 
plus "late" mitotic cells. As can be seen in Table IV the addition of 
"late" mitotic cells to the unequivocally binucleated cells failed 
to impart statistical significance to our data. 
Data from Fliedner et al. was derived from bone marrow 
aspirations obtained 3.5 years after exposure, while the data in 
this study was obtained from marrows 5 years post-exposure. It is 
conceivable that a five year hiatus allowed enough time for the marrows 
to normalize. Fliedner had reported mitotically connected abnor¬ 
malities in 50% of cells from each of his acute, post exposure 
marrows. By three and one half years the incidence of mitotic 
abnormalities had dropped to approximately 4% of cells in each 
% 
marrow. Though there is little basis for extrapolating this data, 
one might conjecture that, had bone marrow examinations been performed 
on Oak Ridge group at a point beyond three and one half years, 
differences between controls and exposed might have become insign¬ 
ificant. 
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Though Fliedner et al. emphasized the frequency of binu- 
clearity in their exposed cohort, it should be mentioned that bi- 
nuclearity is not a unique marker for radiation exposure. Erythro¬ 
blastic binuclearity is one of the hallmarks of a relatively rare 
refractory anemia described by Wendt and He impel (33) in 1967. 
This unusual anemia was defined as Congenital Dyserythropoietic Anemia 
(CDA) and subsequently divided it into three types (34). Multi- 
nuclearity in the red cell series is a coninon feature in all three 
types, with a frequency of approximately 10-50% of the erythroblasts 
(35) . Essentially, the characteristics of CDA are those of ineffective 
erythropoiesis; inappropriately low reticulocyte counts coupled 
with marked erythroid hypeiplasia in the marrow and rapid clearance 
of radioactive iron from the plasma with subsequent poor utilization 
(36) . The etiology of this dyserthropoiesis remains unknown. 
Binuclearity (at a lower rate that in CDA) is also a common 
finding in bone marrows associated with other disease processes. 
Megaloblastic anemias are frequently associated with a striking 
erythroblastic multinuclearity (36-38). Schwarz (39) states 
that the frequency of binucleated cells in a given marrow roughly 
parallels the regenerative activity of the erythroid precursors and 
is a frequent finding in hemolytic anemias. This has been noted by 
others as well (38,40,41). Binuclearity is often reported in 
erythroleukemia (40,41). There have been spurious reports of 
binucleated erythroblasts in iron deficiency (41) as well as vitamin 
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E deficiency (42). 
The significance of binucleated erythroblasts is obscure. 
Though associated with radiation injury as well as several disease 
states, they can also be a common finding in normal marrcws. 
Berman (38) examined the marrows of 8 healthy individuals and 
noted the incidence of plurinuclear erythroblasts to vary from 1.0- 
5.1 per 1000 uninuclear erythroblasts. In the four controls of 
Fliedner et al. a mean incidence of binucleated erythroblasts was 
1.2, while the mean for the high dose group was 5.1 per 1000. Both 
values are within the range of Berman's normals. Fliedner et al. 
noted this and states that a statistical comparison was only made with 
their own controls since they were studied in the same manner as 
their irradiated subjects. 
Schwarz (39) observed that in normal marrows the most common 
binucleated erythroblasts were generally mature and close to 
denucleation, with the cytoplasm being orthochrcmatic or slightly 
polychromatic. He found it exceptional for a nuclei to retain 
proerythroblastic features. In the "late" bene marrows from 
Oak Ridge, Fliedner et al. emphasized the occurrence of "early" 
binucleated erythroblasts (corresponding to proerythroblasts and 
basophilic normoblasts) should be considered abnormal. The incidence of 
"early" binucleated erythroblasts in theix high dose group was 
1.4 compared to essentially zero in the low dose and control groups. 
Table gives the incidence of early binucleated erythroblasts 
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per 1000 in our study. The incidence is small for exposed subjects 
in all dose groups as well as the controls. There is an apparent 
gradient with dose but it is not statistically significant. 
In our study the occurence of karycmeres was also a 
frequent finding in most of the marrows. Despite a dramatic 
increase in the 600+ rad group/ a statistically significant 
gradient with dose was not established. As was mentioned, Fliedner 
et al. reported an increased number of erythroblasts with karycmeres, 
but absolute numbers were not reported. The term karyanere was used 
by Schwarz (39) to describe aberrant nuclear fragments. There is 
probably little difference between karycmeres and Howell-Jolly bodies 
other than extrusion of the nucleus in the latter. Disccmbe (43) 
demonstrated that Howell-Jolly bodies evolve from chranoscmes that 
fall away from the mitotic spindle during abnormal mitosis. Pre¬ 
sumably1, at the completion of mitosis these fragments coalesce into 
smaller nuclear bodies. Bessis (44) has examined Hcwell-Jolly bodies 
with the electron microscope and from his studies it appears that 
they are surrounded by normal nuclear merrforane. 
In an animal study, Fliedner (21) irradiated rats and 
\ 
injected them with tritiated thymidine. prior to sacrifice within 
the first 24 hours post exposure. He found that these aberrant 
nuclear fragments (karycmeres) were labeled, indicating that they 
still retained the capacity to synthesize DMA. He made the point 
that, in a functional sense, karycmeres must be considered to be 
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ectopic nuclear material and not mere remnants of karyorrhexis. 
Though "bridging" between chromosomal material in mitotic 
cells is a well described sequela of acute radiation damage, the 
present study does not indicate that bridging can be used as a 
reliable marker of persistent radiation injury. Its incidence was 
quite rare and its absence in the control was insignificant. 
Fliedner et al. do not give exact figures but state that abnormal 
mitoses, including mitotic bridges and aberrant chromosomes, were 
as high as 50% in the acute marrow of the high dose group. In the 
"late" study, they report inter-chrcmoscmal bridging only in the 
myelocytic cells. 
Pluripolar mitoses were uncommon in our study and had no 
significance as a radiation marker. Fliedner et al. attached seme 
importance to their finding of three independent tripolar mitoses in the 
high dose group, noting that Berman failed to observe a single 
pluripolar mitosis in 53,167 erythroblasts of 8 health controls. 
The fact that it is seen so infrequently and so inconsistently does 
not lend itself to a study of statistical significance, and leaves 
the observation of dubious importance. 
The most interesting finding in our review of "late" 
marrows was the occurence of intemuclear bridges in seven of the 
survivors. Though found mainly in the heavily irradiated subjects, 
its incidence was once again too infrequent to be used as a reliable 
radiation marker and even less so as a dosimeter. 
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Intemuclear bridging is a rare finding. It has been 
reported in the Congenital Dyserythropoietic Anemias. Inter- 
nuclear bridges serve as one of the distinguishing features 
of the so-called-type I CDA C35,36). Lewis et al. (41) have done EM 
studies on CEA, type I, and have demonstrated a narrow sheath of 
cytoplasm surrounding the chromatin like strand of material that 
bridges the nuclei of the two, otherwise distinct, erythroblasts. 
This phenomenon is dramatically demonstrated in figure 20 from 
our study. 
It is possible that these intemuclear bridges found 
in interphase cells are the end result of a process which began 
as chromosomal bridging in a mitotic cell. In autoradiographs 
of marrow obtained from subjects exposed to large doses of ionizing 
radiation and then incubated in vitro with tritiated thymidine, 
Fliedner (45) reported one instance in which an intemuclear bridge 
was labeled along with the two nuclei which it connected. The inference 
drawn was that the intemuclear bridge was still functional chrcmatin- 
like material, able to synthesize DNA in conjunction with both nuclei. 
As was mentioned, criteria for identification of 
intemuclear bridges were very strict. Pure cytoplasmic bridges 
were not included. Fliedner does not appear to differentiate 
between intemuclear bridging and cytoplasmic bridging between 
two interphase erythroblasts. In his study of late marrows he 
states that he did not quantitate the apparent increase in red 
cell precursors with cytoplasmic bridges between cells in the high 
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dose group. Lewis (41) has investigated cytoplasmic bridging with 
the aid of an electron microscope and has demonstrated what appears 
to be a spindle bridge consisting of microtubules, sheathed by cytoplasm, 
running between two erythroblasts. Schwarz also noted intercellular 
cytoplasmic bridging and attributed it to "residual interzonal fibers". 
In our study, intercellular bridging, purely by cytoplasmic 
extension, was not enumerated because it was felt that this could be 
an artifact of preparation. Without the aid of an electron microscope 
to clearly demonstrate micro-tubular structures streaming down a tube 
of cytoplasm from one tube to the next, one could not be sure that he 
was not simply viewing 'sticky' membranes from two cells that had 
been juxtaposed during preparation. On the other hand, the observation 
of chromatin material connecting two separate interphase erythroblasts 
is unlikely to be artifactual. Though internuclear bridging was not 
observed frequently enough in the exposed cases to be a statistically 
valid dosimeter of radiation injury, it remains a curious finding in 
these 'late' marrows. 
The "Mitotic Index" is an indication of the proliferative 
capacity of the marrow C46) . In an earlier paper, Fliedner points 
out that determining the mitotic indices from ordinarily prepared 
bone marrow smears is inaccurate. Mitosis should be properly enumerated 
in Feulgen squash preparations. In our study, with Fliedner's caution 
in mind, mitoses were recorded in the course of counting 4000 
erythroblasts. Without regard to specific cell type, our rough 
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mitotic index has a statistically suggestive gradient with increasing 
dose (Table VI ). The rough mitotic index was 6/1000 for the control 
cohort and 10/1000 for the 600+ rad group. Both animal and plant 
experiments have demonstrated that exposure to ionizing radiation 
can cause a lengthening of the mitotic interval. If a cell, damaged 
by radiation, were to spend a longer time in mitosis, the prob¬ 
ability of observing an anaphase or teleophase cell at any one 
point in time would be increased. Thus, as Fliedner points out, 
radiation injury might give a misleadingly high mitotic index. 
Because the mitotic index in our study was determined 
without Feulgen-squash preps and the different cell lines in 
mitosis were not differentiated, little significance in terms 
of radiation injury can be appropriately attributed to the 
suggestive gradient with dose. In his study of the Oak Ridge 
survivors, Fliedner did prepare Feulgen-squash preparations on the 
late marrows and the mitotic indices were not found to be statistically 
different from the controls. 
The only other significant report on persisting bone 
marrow cytologic abnormalities stem from an accidental exposure 
to fallout radiation in the Marshall Islands in 1954. The incident 
occured during a nuclear test in the Marshall Islands (Bikini 
lagoon). Full details of the incident and the subsequent medical 
findings from the people exposed are contained in a twenty year 
review (17) . The most heavily exposed population was a group of 
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64 people inhabiting Rangelap Island. Their entire exposure was in 
the form of fallout with radiation with a maximum estimated whole body 
dose of 175 rad. Bone marrow aspirations frcm four exposed and 
two control subjects were obtained nine years after the accident. 
Oonard notes that, in addition to erythroid hyperplasia, there were 
"abnormalities of the chromatin material" with binucleation and an 
increased frequency of mitotic figures in the normoblastic series." 
Neither absolute numbers nor statistical significance was reported.. 
During the course of this accidental fallout in the Marshall 
Islands, 23 Japanese fisherman aboard the fishing vessel "Fukuryu- 
maru" (the "Lucky.Dragon") were also subjected to fallout frcm the 
atomic detonation approximately 90 miles away. Kumatori (47) has 
reported on the bone marrow findings in this group of men, exposed to 
whole body radiation in the range of 170-700 rad. Of note, "late" 
marrows were aspirated on 14 exposed and 4 controls in 1964, 10 
years after the initial exposure. Kumatori reviewed the marrcws 
in a manner similar to that of our study. They also failed to 
demonstrate a significant difference between exposed and control 
marrows for binucleated erythroblasts (mean of 2.0 for exposed 
versus 1.6 for controls). Three individuals in the exposed group 
had a relative increase in karycmeres in comparison to both controls 
and others in the exposed group. No other cytologic abnormalities 
were reported. 
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Section 6 
OQNCmSION: 
Fran this study it appears that "late" bone marrow cytology 
is not a reliable dosimeter or marker of radiation injury. A cohort 
of survivors was used in which many had been exposed to very high 
doses of ionizing radiation. A significant gradient was not established 
for any of the abnormalities in bone marrow cytology that have been 
associated with both acute and persistent radiation injury. One 
interesting finding was the occurence of intemuclear bridges in 
seven of the marrows from exposed subjects. It is conceivable that 
this cytologic aberration could be used as a marker of radiation 
injury but the occurence is too infrequent to be of value as a biologic 
dosimeter. 
The findings of this study also suggest that a gradual 
disappearance of radiation induced late bone marrow changes continues 
for periods of three to five years or more following acute radiation 
exposure in the high dose range. 
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PART II 
THE LONG TERM EFFECTS OF RADIATION ON ABSOLUTE LYMPHOCYTE 
COUNTS IN THE ADULT HEALTH STUDY SAMPLE- 
HIROSHIMA. - NAGASAKI, JAPAN 
Section I. INTRODUCTION 
A study was undertaken to tabulate absolute lymphocyte counts 
in a large population of atonic bomb survivors in addition to non- 
exposed controls. The data spans a sixteen year .period beginning 
twelve years after exposure. An attempt was made to isolate possible 
perturbations in absolute lymphocyte counts due to persisting radiation 
injury and/or age. 
Section 2 
MATERIALS: 
The Adult Health Study Sample 
The Adult Health Study Sample (AHS) is the major population of people 
who are evaluated by both clinical and laboratory parameters at 
RERF. The AHS includes heavily irradiated survivors and controls 
matched to age, sex and city. Subjects for the AHS were chosen 
from a 1950 A-bonb survivors survey, in addition to other censuses, 
and were divided into four groups: 
GROUP I_: survivors located less than 2000 meters from 
the hypocenter who reported acute radiation 
symptoms (n = 4993) 
GROUP II: Survivors located less than 2000 meters from 
the hypocenter who did not report acute radiation 
symptoms, (n = 4987) 
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GROUP III: survivors located 3000-3499 meters from 
the hypocenter in Hiroshima and 3000-3999 
meters in Nagasaki, (n = 4990) 
GROUP IV: Not in the city (NIC) at the time of blast 
(ATB). (n = 4992) 
The subjects in Group I, by nature of their high exposure 
comprise the center of interest in the AHS. The other three 
groups were conceived in relation to it, matching closely with 
regard to age, sex, and number. In 1958, biennial examinations 
were initiated for-this cohort of approximately 20,000 people. 
These examinations were conducted at ABCC facilities in both Hiroshima 
and Nagasaki. In addition to extensive history taking and physical 
examination, routine laboratory analyses (complete blood counts, 
urinalysis, etc.) were performed on all subjects. Where indicated, 
further testing was undertaken. Participation in this study was 
on a voluntary basis. Belsky, in his review of the first five 
cycles of examination (48) notes "....concern over health, 
cultural inclination toward group participation, fear of unknown 
radiation effects, reward of a hopefully normal examination, etc, 
all play a part (in continuing participation)...". The eighth 
examination cycle (1974-76) is currently being completed. All 
data from the clinical laboratories, spanning the first seven 
examination cycles, is on magnetic tape and accessible through 
an IBM 1440 computer, on site in Hiroshima. 
55 

Section 3 
METHODS: 
Data concerning lymphocyte counts was stored in the form 
of total white blood cell counts, coupled with corresponding white 
cell differentials. This data was easily converted to absolute 
lymphocyte counts by the simple calculation: 
ABSOLUTE LYMPHOCYTE COUNT = total WBC X % lymphocytes 
Data from examination cycle I (1958-60), IV (1964-66), and VII 
(1970-72) were analyzed independently. The data was tabulated in 
a matrix fashion with age (00-29, 30-39, 40-49....) on the abscissa 
and T65D dose (NIC, 0-9, 10-49, ...) on the ordinate. As indicated 
below, each entry into the matrix consisted of: n - (the number in 
that coordinate), mean - (mean absolute lynphocyte count for that 
nurnber), and S.D, - (the standard deviation) . 
:...00-29....AGE 
DOSE 100-199r 
n = 197 
mean = 2086 
SD = 758 
A pure "aging" effect was looked for in the non exposed group (NIC). 
Both a radiation and an "aging" effect was sought for in the exposed 
groups. 
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Section 4. 
RESULTS: 
A. The effect of previous radiation exposure on the 
absolute lymphocyte count. 
The results of the three examination cycles analyzed gj-Q 
summarized in Tables I-III. There appears to be no relation between 
the magnitude of the absolute lymphocyte counts and the extent of 
radiation exposure. Figures (cycles I, IV, and VII respec¬ 
tively) represent this data in graphic fashion. One can control for 
age with these graphs by selecting a specific bar pattern and following 
it along the abscissa. For all three cycles, with age controlled, 
there is no consistent relationship between radiation dose and the 
absolute number of lymphocytes. 
B. The effect of AGE on the absolute lymphocyte count. 
Figures 4-6 are taken from Tables I-m respectively. 
They graphically demonstrate a significant diminution in the 
absolute lymphocyte counts in the 70+ age group. This finding holds 
true for all three examination cycles and for all groups, whether 
heavily irradiated or unexposed (i.e. not in city ATB). Table IV 
analyzes the data in a different fashion, with the mean absolute, 
lymphocyte counts transformed by / ~ (49) . For each of the three 
cycles, the mean lymphocyte count for the 70+ age group is sign¬ 
ificantly less (p < .0001) than that of all individuals aged 0-69, 
combined. 
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FIGURE I 
EFFECT of radiation on absolute lymphocyte count 
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FIGURE 2 
EFFECT OF RADIATION ON ABSOLUTE LYMPHOCYTE COUNTS 
MEAN ABSOLUTE LYMPHOCYTE COUNT BY DOSE - FOURTH CYCLE EXAMINATION 
1964 - 66 
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FIGURE 3 
EFFECT OF RADIATION ON ABSOLUTE LYMPHOCYTE COUNTS 
MEAN ABSOLUTE LYMPHOCYTE COUNT BY DOSE - SEVENTH CYCLE EXAM. 
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FIGURE 4 
EFFECT OF AGE ON ABSOLUTE LYMPHOCYTE COUNTS 
MEAN ABSOLUTE LYMPHOCYTE COUNT BY AGE - FIRST CYCLE EXAMINATION 
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FIGURE 5 EFFECT OF AGE ON ABSOLUTE LYMPHOCYTE COUNTS 
MEAN ABSOLUTE LYMPHOCYTE COUNT BY AGE - FOURTH CYCLE EXAMINATION 
1964 -66 
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FIGURE 6 
EFFECT OF AGE ON ABSOLUTE LYMPFDCYTE COUNTS 
■% 
MEAN ABSOLUTE LYMPHOCYTE COUNT BY AGE - SEVENTH CYCLE EXAMINATION 
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TABLE I 
NIC 
0-9 
10-49 
50-99 
100-199 
200-299 
300+ 
TOTAL 
ABSOLUTE LYMPHOCYTE COUNTS, FIRST CYLCLE EXAM (1958 -60) 
AGE 
0-29 30-39 40-49 50-59 60-69 70+ TOTAL 
607 740 559 580 393 130 3009 
2180 2111 2078 2216 2055 1996 2127 
744 750 739 810 834 681 769 
879 875 650 739 517 181 3841 
2138 2041 2131 2172 2103 2060 2113 
757 713 748 840 855 806 780 
364 372 386 • 4*54 287 125 1988 
2105 2105 2063 2165 2088 1949 2098 
778 744 742 805 815 851 782 
169 231 162 214 158 44 958 
2096 2068 2029 2167 1980 1838 2065 
727 728 751 S66 698 629 759 
197 283 158 204 117 25 984 
2086 2059 1966 2122 2017 1935 2054 
758 740 743 787 786 707 759 
106 171 89 85 58 12 521 
2186 1996 2020 2013 1993 2037 2042 
757 640 820 592 743 795 707 
164 192 89 111 79 19 654 
2247 2051 2000 2186 2259 2027 2141 
820 729 756 S28 927 772 803 
2552 3033 2162 2449 1616 542 12354 
2143 2074 2074 2172 2073 1988 2104 
757 727 747 816 823 768 771 
n= number 
each entry- mean absolute lymphocytes 
standard deviation 2 
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TABLE I 
NIC 
0-9 
10-49 
50-99 
100-199 
200-299 
300+ 
TOTAL 
ABSOLUTE LYMPHOCYTE COUNTS, FOURTH CYCLE EXAM (1964-66) 
each entry— 
AGE 
* 
0-29 30-39 40-49 50-59 60-69 70+ TOTAL 
245 288 639 612 550 225 3059 
2094 2109 1972 2114 1990 iMi 2038 
672 738 659 738 703 646 709 
320 1102 774 749 717 308 3970 
2061 2071 1988 2139 2011 1864 2040 
620 701 674 761 736 715 712 
169 380 359 432 412 170 1922 
2041 
670 
2109 
683 
2097 
753 
2114 
741 
1975 
782 
1810 
639 
2047 
732 
52 244 198 179 196 67 936 
1994 1979 2006 2042 1965 1724 1976 
620 640 726 62.7 738 725 685 
81 350 223 186 194 71 1105 
2014 2073 1939 2143 2025 1978 2039 
600 706 696 722 912 744 744 
55 203 135 107 85 37 622 
1928 2004 1937 2164 1958 2114 2011 
596 772 661 712 712 944 730 
95 216 128 no 114 44 707 
2130 2136 2084 2074 2215 - 2047 2123 
782 697 761 721 696 652 721 
1041 . 3484 2574 2450 2323 937 12809 
2050 2074 2004 2123 2005 1865 2041 
654 709 692 740 752 697 718 
~n= number —■ 
mean absolute lymphocytes 
standard deviation 
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TABLE III 
ABSOLUTE LYMPHOCYTE COUNTS, SEVENTH CYCLE EXAM (1970-72) 
AGE 
0-29 30-39 40-49 50-59 60-69 70+ TOTAL 
67 322 807 499 499 354 2548 
NIC 2167 2060 2064 2067 2010 1792 2018 
775 709 704 689 701 665 704 
93 448 1013 649 674 487 3364 
0-9 2077 2096 2048 2095 1935 1758 2000 
650 686 693 729 696 618 697 
39 178 386 325 377 23S 1543 
10-49 1969 2085 2053 2136 1968 1739 21m 
568 740 690 739 731 642 717 
10 75 288 150 160 105 788 
50-99 1912 1981 2013 2088 1926 1689 1962 
603 594 642 657 638 590 642 
18 89 364 189 164 111 935 
100-199 2004 2040 1968 2042 1888 1643 1938 
620 589 681 708 638 671 677 
12 57 213 107 83 53 525 
200-299 1823 2094 1964 2149 1922 1779 1987 
612 902 676 889 672 649 751 
36 85 225 91 93 63 593 
300+ 2519 2316 2137 2048 2024 1835 2122 
795 916 736 768 650 612 763 
283 1293 3519 2089 2108 1441 10733 
TOTAL 2114 2087 2042 2094 1959 1757 2005 
698 719 694 727 690 637 704 
| n= number 
each _entry mean absolute lymphocytes 
|, standard deviation 
TABLE IV MEAN ABSOLUTE LYMPHOCYTE COUNTS 
TRANSFORMED BY THE SOUARE ROOT 
AGE 
Cycle # 
0-69 70+ significance 
I 44.72 43. 3 p = .000075 
II 44.63 42.4 p = < 10'16 
III 44.52 41.2 p = < 10'24 
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Section 5 
DISCUSSION; 
A. Radiation exposure and absolute lymphocyte counts 
Though no persisting effects of radiation on absolute lymphocyte 
counts was detected, a positive finding would not have been a surprise. 
Acutely, lymphocytes are exquisitely sensitive to radiation. Cronkite 
and Bond (50) have ranked mammalian tissue in order of decreasing 
susceptibility to radiation: 
1. Spermatogonia 
* 2. Lymphocytes 
3. Erythroblasts 
4. Remaining classical hematopoietic tissues 
5. Epitheliumof small intestine 
6. Stomach 
7. Colon 
8. Skin 
9. CNS 
10. Muscle 
11. Bone 
12. Collagen 
With in vitro studies, Schrek (51) has demonstrated marked 
destruction of normal lymphocytes following exposure to as little 
as fifty rad of ionizing radiation. Following whole body irradiation. 
there is a rapid decline in lymphocytes frcm the peripheral blood. 
lymph nodes, thymus, spleen and other lymphoid tissues (20). This 
abrupt fall in lymphocyte population cannot be explained solely on 
the basis of damage to lymphocyte producing stem cells as even short 
lived lymphocytes have a relatively long intermitotic period (52). 
It is generally agreed that ionizing radiation has a "lympho-cytolytic" 
action similar to the action of pharmacological dose of corticosteroids. 
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of the atonic blasts in Hiroshima and Nagasaki had not been complete. 
The early findings were reported by Blaisdell (22) in a summary of 
hematological studies performed at the Atomic Bcmb Casulaty Carmission, 
in both cities, during the years 1947-59. In 1947-48 (19-32 months 
after exposure) the HE 67 survey of Hiroshima survivors was undertaken. 
The HE67 survey was a collection of 924 Hiroshima survivors, selected 
frcm greater than 16,000 people who had admitted on a questionaire 
to a history of epilation within 130 days of the atonic blast. 
At that time, whole body gamma radiation exposure was estimated 
to be 300-700 rad for this cohort (even though 20% of the individuals 
were more than 2000 meters frcm the hypo center). The control sample 
consisted of 995 individuals from Kure city (approximately 50 km 
from Hiroshima). Leukocyte counts and white cell differentials 
were performed. Though the total leukocyte counts were approximately 
the same in both the exposed of Hiroshima and the Kure controls, 
the relative lymphocyte count was slightly lower and the eosinophil 
count slightly higher in Hiroshima. 
In 1948-49, a followup HE 67 survey with a similar but 
not identical sample failed to demonstrate a difference in lymphocyte 
percentages between Hiroshima survivors and Kure controls. 
During the years 1953-56 the ME 74 survey was conducted 
in Hiroshima. This sample was designed to focus on a population 
of heavily irradiated survivors. It consisted of 5000 adults 
who reported themselves to have been within a 2000 meter radius 
* 
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of the hypocenter at the time of the blast and who gave a history 
of epilation, purpura or oropharyngeal ulceration. The "control" 
cohort was made up of a group matched for age and sex, who were 
reportedly 3000-3500 meters from hypocenter. There were no significant 
differences in lymphocyte percentages between exposed and "controls". 
The results of the first five cycles of examination 
(1958-68) in the Mult Health Study Sample at ABCC were reported 
by Belsky et al (48). The effect of radiation on the lymphocyte 
counts were not analyzed at that time. The present study investigated 
this question for three isolated cycles. 
In attempting to look retrospectively at absolute lymphocyte 
counts in the AHS, one must be aware of several confounding problems 
before trying to infer correlations with radiation exposure: 
1) Blaisdell has noted that there was a fall in the mean 
leukocyte count in Hiroshima during the period of 1947-56 (9000/cc 
to 5500/cc). He points out that this decline was coincident with 
controls, and therefore not a radiation effect. White-cell differ¬ 
entials did not change significantly during the same period so that 
the absolute lymphocyte counts fell proportionately. A similar 
decline, during the same time, was noted in Nagasaki, albeit the 
absolute figures were slightly higher than in Hiroshima. As well, 
a general decline in leukocyte counts throughout Japan was suggested 
at that time. The decline in WBC is believed to be related to a 
reduction in intestinal parasitism and a shorter duration of bacterial 
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infections in the resident populations of Japan, coincident with 
improved hygiene standards and the introduction of antibiotics 
during this period. In reviewing white blood cell councs from the 
five cycles of examination, 1958-68, values appear to have stabilized. 
2) It seemed probable that age at time of blast, as well 
as the vagae phenomenon of "aging" might have an effect on absolute 
lymphocyte counts and needed to be controlled for if one was to look 
for an isolated radiation effect. The singular effects of "aging" 
on absolute lymphocyte counts will be discussed in the next section 
("Aging" and the Lymphocyte) though a brief discussion of the 
possible potentiation of radiation effects by age will follow. 
Experimental studies on rats and mice (58-59) have 
shown that the age of the animal at the time of irradiation 
plays a significant role in the development of "late" radiation 
effects (i.e. induction of neoplasms, Tens opacities, life short¬ 
ening. .). The late effects were greater in those animals exposed 
at a young age, dropped off with exposure at increasingly older 
age groups, and often showed a second peak with exposure at a very 
old age. Jablon and Kato (7) , in studying the mortality of A-bcmb 
survivors, reached a similar conclusion in regard to the leukemogenic 
effects of radiation. They reported that those most susceptible 
to this effect were either in the youngest or oldest age brackets 
at the time of exposure, while those in the intermediate age grouping 
(10-49) had a significantly lower risk. 
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The supposition that radiation could effect lymphocytes, 
years after exposure, is not without seme precedence. Awa et al (12) 
has described chromoscinal aberrations in circulating lymphocytes 
from atonic bomb survivors, twenty years after exposure. Though 
the isolated effects of radiation and "aging" might be too small 
to be detected, a potentiation, through the combination of the 
two, might be appreciated though it was not detected in the present 
study. 
3) Lymphopenia is not unique to acute radiation exposure. 
Cassileth (60) has catalogued multiple causes of lymphopenia including 
irtirtunoglubiilin disorders (e.g. Wiskott-Aldrich Syndrome, thymic 
abnormalities), intestinal lymph loss (e.g. thoracic duct drainage, 
impaired intestinal lymph drainage as in Whipple's disease, severe 
right-sided heart failure), increased lymphocyte destruction (e.g. 
acute radiation exposure, chemotherapy, increased plasma oorticoids) 
as well as a myriad of miscellaneous maladies including Hodgkin's 
disease, aplastic anemia, sarcoid, acute and chronic renal failure, 
terminal carcinoma and miliary tuberculosis. In order to isolate a 
pure radiation effect on absolute lymphocyte counts, the sample size 
must be large enough to render the relative effect of any of these 
other causes of lymphopenia (each with a small incidence) insignificant. 
It was felt that the sample size of approximately 20,000 people was 
large enough to provide this "washout" effect. 
4) Absolute lymphocyte counts give no information concerning 
the relative population of B or T cells. It is conceivable that one 
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In animal studies, Hulse (53) described a bimodal disappearance of 
lymphocytes frcxn the peripheral blood and bone marrow following 
sublethal irradiation. After a rapid decline in the majority of 
circulating lymphocytes, there was a slower drop off in the remaining 
population. This was understood to represent a initial "cytolytic'' 
effect on mature lymphocytes followed by a slower decline due to 
failure of production by lymphopoietic cells. 
In contrast to an isolated exposure to high doses of 
radiation, the effects of low dose, chronic radiation exposure 
(e.g. radiation workers, radiologists) on absolute lymphocyte 
counts have usually been towards lymphocytopenia, associated with 
a mild leukopenia (20). However, there have also been reports of 
leukocytosis with lymphocytosis (54-55). 
The rate and extent of recovery frcm severe post-irradiation 
lymphocytopenia has not been well documented. Wald (20) has pointed 
out that the time intervals in the sequential depletion,reappearance, 
and complete reestablishment of lymphocyte populations has a 
variance with species as well as with the extent of exposure. In 
a study involving rabbits exposed to large doses of radiation 
(300 rad) lymphocyte recovery was incomplete at three months (56). 
Canard, in reporting cn the Marshallese, a population exposed to 
fallout radiation, noted a relative lymphocyte deficit in the exposed 
cohort up to eight years after the accident (57). 
Late studies on lymphocyte populations in the survivors 
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/ 
of these sub-populations could decrease with a compensatory increase 
in the other, yielding a normal absolute lynphocyte count. Data 
on B and T lynphocyte populations are not available from the AHS 
sample. Hopefully, in future years, with the implementation of 
simpler techniques for enumeration, these two populations of 
lymphocytes will be critically evaluated. 
5) A cross-sectional approach (i.e. looking at an 
isolated cycle examination) is not ideal in that it lends itself 
to a selection bias. Subjects exposed at an old age might be the 
individuals who have age-related changes in their absolute lynphocyte 
counts. At the point in time where the cross sectional analysis 
is made, these individuals might no longer be living. A more 
ideal approach would be to follow any particular individual, long¬ 
itudinally, through all examination cycles. This type of study 
will soon be undertaken at RERF. 
B. Aging and the Lynphocyte 
In the course of analyzing absolute lynphocyte counts for 
radiation effects, it was necessary to look at the isolated effect 
of age, at time of examination, in order that it might be controlled 
for when assessing radiation effects. As well, absolute lynphocyte 
counts in aging populations is a phenomenon with its cwn significance, 
independent of prior radiation exposure. 
As the prototypical immunocyte, the lynphocyte is the 
focus of attention in the controversial irnnunologic theory of 
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aging; a theory proposed most notably by Walford (gp). In essence, 
the theory purports that failure of the imnune system leads to 
accelerated senescence by leaving the organism vulnerable to infection 
neoplasia and the so-called "auto-immune" diseases. This failure 
can cane about either by failure of lymphocyte function or by simple 
reduction in the number of immunocytes. Lymphocyte function (e.g. 
response to allogeneic lymphocytes, poke-weed mitogens, and phyto- 
hemaglutinin, as well as delayed hypersensitivity reactions) has been 
shown to be impaired with increasing age (17,62-64) . The effects 
of age and/or "aging" on absolute lymphocyte counts, as well 
as B cell and T cell counts, have not been well documented. It is 
known that there is a continuous decline in the absolute lymphocyte 
count from infancy to puberty (approximately 5000/cc to 2000/cc). 
Betke (65) states that frcm puberty to advanced old age (90 years) 
no further changes occur. Vfeksler (64) reported indentical percentages 
of B and T cells in both a young (25-40) and old (75-96) age group. 
Shapleigh (66) as well, claims the absolute number of lymphocytes do 
not change as a function of age. Opposed to this is a recent pub¬ 
lication (67) which compared a middle aged group of people with a 
cohort aged 65-86 and found a moderate lymphopenia in the older age 
group. Corosella (68) noted a significant fall in rosette forming 
T cells in a group aged 46-60. Conard (17) in his twenty year 
review of findings in the Marshallese, reports a very slight reduction 
in lymphocytes with increasing age in both the exposed and nan-exposed 
groups. 
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Though Belsky, in his report on the first five examination 
cycles of the AHS at ABCC, states that the differential counts showed 
no age relationship, he also notes that the absolute lymphocyte counts 
were not examined. In the same section he states that, in general, 
white blood cell counts did decrease with age; the inference being 
that the absolute lymphocyte counts decreased proportionately. 
In the present study, we were able to demonstrate a sign¬ 
ificant (p<.0001) drop of approximately 10% in absolute lymphocyte 
counts in the 70+ age group. Though this phenomenom has been suspected 
for aging populations throughout the world, this is the first study 
with a sample size large enough to convincingly denonstrate it. It 
is unclear whether the magnitude of this drop is sufficient to account 
for a reduction in immune surveillance to level where malignancies 
and autoimmune disorders become manifest. 
Section 6 
CONCLUSION: 
This study demonstrates that absolute lymphocyte counts are 
not reliable markers of radiation injury except during the acute 
exposure period. A shift in the ratio of T and B lymphocytes without 
a reduction in the absolute number of lymphocytes was not ruled out. 
An important finding unrelated to radiation exposure was 
the demonstration of a significant drop in absolute lymphocyte counts 
in a 70+ age population. 
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